trial · primary record
Campath
X-linked Severe Combined Immunodeficiency (XSCID)
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2032-12-31 |
| Primary endpoint | Early evidence for efficacy will be defined by appearance and expansion in the circulation of autologous transduced T-lymphocytes with functional gmama-c and improved laboratory measures of immune function in the interim evaluation of these para... |
| Registry ID | NCT01306019 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:46.220Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01306019
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.